BM

Brian R. Murphy

US US Dept of Health & Human Services: 22 patents #13 of 3,044Top 1%
TA The United States Of America: 4 patents #2 of 521Top 1%
UA US Army: 3 patents #18 of 341Top 6%
SR Scripps Research: 3 patents #296 of 1,293Top 25%
SH St. Jude Children'S Research Hospital: 2 patents #108 of 351Top 35%
CF Cornell Research Foundation: 1 patents #802 of 1,638Top 50%
AP Amerimas Home Products: 1 patents #421 of 715Top 60%
📍 Bethesda, MD: #3 of 2,269 inventorsTop 1%
🗺 Maryland: #87 of 35,612 inventorsTop 1%
Overall (All Time): #22,387 of 4,157,543Top 1%
80
Patents All Time

Issued Patents All Time

Showing 1–25 of 80 patents

Patent #TitleCo-InventorsDate
12203100 Development of dengue virus vaccine components Stephen S. Whitehead, Joseph E. Blaney, Ching-Juh Lai 2025-01-21
11753627 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 Stephen S. Whitehead, Lewis Markoff, Barry Falgout, Joseph E. Blaney, Kathryn A. Hanley +1 more 2023-09-12
11746335 Development of dengue virus vaccine components Stephen S. Whitehead, Joseph E. Blaney, Ching-Juh Lai 2023-09-05
11400150 Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus Alexander G. Pletnev, Joseph R. Putnak, Robert M. Chanock, Stephen S. Whitehead, Joseph E. Blaney 2022-08-02
11332722 Development of dengue virus vaccine components Stephen S. Whitehead, Joseph E. Blaney, Ching-Juh Lai 2022-05-17
11318196 Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein Stephen S. Whitehead, Kathryn A. Hanley, Joseph E. Blaney, Ching-Juh Lai 2022-05-03
10980872 Genetically stable live attenuated respiratory syncytial virus vaccine and its production Peter L. Collins, Cindy L. Luongo, Ursula Buchholz 2021-04-20
10869920 Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus Alexander G. Pletnev, Joseph R. Putnak, Robert M. Chanock, Stephen S. Whitehead, Joseph E. Blaney 2020-12-22
10837003 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4 Stephen S. Whitehead, Lewis Markoff, Barry Falgout, Joseph E. Blaney, Kathryn A. Hanley +1 more 2020-11-17
10724007 Development of dengue virus vaccine components Stephen S. Whitehead, Joseph E. Blaney, Ching-Juh Lai 2020-07-28
10561724 Live attenuated virus vaccines for La Crosse virus and other bunyaviridae Stephen S. Whitehead, Richard S. Bennett 2020-02-18
10500264 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses Stephen S. Whitehead, Kathryn A. Hanley, Joseph E. Blaney, Ching-Juh Lai 2019-12-10
10456461 Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus Alexander G. Pletnev, Joseph R. Putnak, Robert M. Chanock, Stephen S. Whitehead, Joseph E. Blaney 2019-10-29
10307476 Genetically stable live attenuated respiratory syncytial virus vaccine and its production Peter L. Collins, Cindy L. Luongo, Ursula Buchholz 2019-06-04
10206995 Live attenuated virus vaccines for la crosse virus and other bunyaviridae Stephen S. Whitehead, Richard S. Bennett 2019-02-19
10160957 Development of dengue virus vaccine components Stephen S. Whitehead, Joseph E. Blaney, Ching-Juh Lai 2018-12-25
10058602 Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus Alexander G. Pletnev, Joseph R. Putnak, Robert M. Chanock, Stephen S. Whitehead, Joseph E. Blaney 2018-08-28
9884104 Live attenuated virus vaccines for la crosse virus and other bunyaviridae Stephen S. Whitehead, Richard S. Bennett 2018-02-06
RE46641 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 Stephen S. Whitehead, Lewis Markoff, Barry Falgout, Joseph E. Blaney, Kathryn A. Hanley +1 more 2017-12-19
RE46631 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 Stephen S. Whitehead, Lewis Markoff, Barry Falgout, Joseph E. Blaney, Kathryn A. Hanley +1 more 2017-12-12
9783787 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4 Stephen S. Whitehead, Lewis Markoff, Barry Falgout, Joseph E. Blaney, Kathryn A. Hanley +1 more 2017-10-10
9707287 Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein Stephen S. Whitehead, Kathryn A. Hanley, Joseph E. Blaney, Ching-Juh Lai 2017-07-18
9624475 Genetically stable live attenuated respiratory syncytial virus vaccine and its production Peter L. Collins, Cindy L. Luongo, Ursula Buchholz 2017-04-18
RE46042 Development of dengue virus vaccine components Stephen S. Whitehead, Joseph E. Blaney, Ching-Juh Lai 2016-06-28
9255252 Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae Stephen S. Whitehead, Richard S. Bennett 2016-02-09